Researchers at Hirotsu Bio Science have now genetically engineered a version of C. elegans that is sensitive to trace amounts of substances produced by pancreatic cancer at its early stages ...
When applied to 29 living C. elegans embryos, ranging from the 4- to 350-cell stages, 3DCSQ successfully identified and ...